Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
86
days
Clinical heterogeneity of signal transducer and activator of transcription 3 gain-of-function syndrome
Authors
Caroline L. Gueniot; Jamie Yeager; Colleen LeBlanc; Ricardo Gomez; Elizabeth L. WisnerShow moreShow less
Affiliations
Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Department of Allergy and Clinical Immunology, North Texas Allergy and Asthma Associates, Dallas, TexasShow moreShow less
110
days
Dupilumab effectiveness and safety in patients with chronic rhinosinusitis with nasal polyps
Authors
Anju T. Peters; Andrew A. White; Shigeharu Fujieda; Enrico Heffler; Kathleen M. Buchheit; Marjolein E. Cornet; Changming Xia; Scott Nash; Mark Corbett; Cristina Almansa; Amr Radwan; Martin WagenmannShow moreShow less
Affiliations
Allergy-Immunology Division and the Sinus and Allergy Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Division of Allergy, Asthma and Immunology, Scripps Clinic, San Diego, California; Department of Otorhinolaryngology, Head and Neck Surgery, University of Fukui, Fukui, Japan; Personalized Medicine, Asthma and Allergy, Istituto di Ricovero e Cura a Carattere Scientifico Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Aspirin-Exacerbated Respiratory Disease Center, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Otorhinolaryngology, Alrijne Hospital, Leiderdorp, Netherlands; Regeneron Pharmaceuticals Inc., Tarrytown, New York; Sanofi, Morristown, New Jersey; Sanofi, Cambridge, Massachusetts; Regeneron Pharmaceuticals Inc., Uxbridge, United Kingdom (former affiliation); Department of Otorhinolaryngology, Düsseldorf University Hospital (UKD), Düsseldorf, North Rhine-Westphalia, GermanyShow moreShow less
44
days
The significant upside of antibiotic allergy testing in patients with Helicobacter pylori
Authors
James A. Goss; Rebecca Lee; Matthew S. Krantz; Elizabeth J. Phillips; Jr Cosby A. StoneShow moreShow less
Affiliations
Internal Medicine Residency Program, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TennesseeShow moreShow less
29
days
Growing into adult care
Authors
Laura J. West; Neha T. Agnihotri; Priya PatelShow moreShow less
Affiliations
Division of Allergy and Immunology, University of Pittsburgh Medical Center Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Section of Allergy and Immunology, Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Allergy and Immunology, Children’s Hospital of Philadelphia, Philadelphia, PennsylvaniaShow moreShow less
39
days
Pharmacokinetics and pharmacodynamics of AQST-109 sublingual film in oral allergy syndrome
Authors
Anna Nowak-Wegrzyn; David M. Fleischer; Jay A. Lieberman; David B.K. Golden; Elisabeth Kilroy; Gary Slatko; Karen Rance; Matthew GreenhawtShow moreShow less
Affiliations
Division of Pediatric Allergy, New York University Grossman School of Medicine, New York, New York; Department of Clinical Pediatrics, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; Section of Allergy and Immunology, Children’s Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado; Department of Pediatric Pulmonology, The University of Tennessee Health Science Center and Le Bonheur Children’s Hospital, Memphis, Tennessee; Division of Allergy and Immunology, Medstar Franklin Square Hospital, Baltimore, Maryland; Aquestive Therapeutics, Inc, Warren, New JerseyShow moreShow less
90
days
Remibrutinib impact on disease control, sleep, and quality of life
Authors
Giselle Mosnaim; Sarbjit Saini; Mark Lebwohl; Simon F. Thomsen; John Reed; Bin Yang; Atsushi Fukunaga; Vipul Jain; Clarice Field; Merin Kuruvilla; El-Djouher Martzloff; Noriko Seko; Pengpeng Wang; Sibylle Haemmerle; Martin MetzShow moreShow less
Affiliations
Division of Allergy and Immunology, Department of Medicine, Endeavor Health, Evanston, Illinois; Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Dermato-Venereology and Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Dermatology, Oxford University Hospitals NHS Foundation Trust and University of Oxford, Oxford, United Kingdom; Department of Dermatology, Dermatology Hospital of Southern Medical University, Guangdong Provincial People’s Hospital, Guangzhou, People's Republic of China; Department of Dermatology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan; Division of Clinical Immunology and Allergy, McMaster University, Hamilton, Ontario, Canada; Novartis Ireland Limited, Dublin, Ireland; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey; Novartis Pharma AG, Basel, Switzerland; Novartis Pharma K.K., Tokyo, Japan; Novartis (China) Biomedical Research, Shanghai, People's Republic of China; Institute of Allergology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology, Immunology and Allergology, Berlin, GermanyShow moreShow less
FAQ
How long does ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY take to review a manuscript?
As of 2026-11-19, CrushSCI has 15 complete review records for ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. The fastest paper went from submission to acceptance in 24 days (Utility of exhaled nitric oxide as a potential biomarker for multiple food allergies in patients without asthma, received 2026-04-06, accepted 2026-04-30); the slowest took 253 days. The average is 86.7 days and the median is 86 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
